FAMHP (Belgian Medicine Agency)

BioVigilance web application launched for reporting adverse events related to substances of human origin

Original title: The new BioVigilance web application is now available

FAMHP launches BioVigilance, an online application for reporting serious adverse events and reactions related to reproductive and non-reproductive substances of human origin intended for human application.

Low obligation Framework Health Data, Privacy & Security General Regulatory Belgium Health dataCybersecurity

The FAMHP launches BioVigilance, a new online application for reporting serious adverse events and reactions related to reproductive and non-reproductive substances of human origin (SoHO) intended for human application.

Read the official source ↗

Published by FAMHP (Belgian Medicine Agency). HealthSignal links to the original document; the summary above is extracted from the source text.